Kim Dong Kyu, Seo Seok Kyo, Han Kichang, Kim Man-Deuk, Kwon Joon Ho, Kim Gyoung Min, Kim Hyung Cheol, Choi Jinyoung, Park Juil, Moon Sungmo, Won Jong Yun
Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul 03722, Korea.
Department of Obstetrics and Gynecology, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Korea.
Eur J Radiol. 2024 Dec;181:111773. doi: 10.1016/j.ejrad.2024.111773. Epub 2024 Oct 4.
To identify factors related to technical outcomes of catheter-directed sclerotherapy (CDS) and suggest selection criteria for CDS in patients with ovarian endometrioma.
This retrospective study included patients with endometriomas treated with CDS between November 2015 and June 2023. The characteristics of the endometriomas, including diameter, morphology (unilocular or multilocular), and T2 signal intensity were evaluated using pre-procedure magnetic resonance imaging. Moreover, the size of the catheter (7- or 8.5-French) and route of access (transabdominal vs. transvaginal) was also analyzed. Multivariate logistic regression analyses were used to identify factors associated with the technical outcomes of CDS.
Technical success was defined as successful completion of the following: 1) insertion of a 7- or 8.5-French catheter into the endometrioma, 2) full aspiration of the internal content, and 3) completion of sclerotherapy without ethanol leakage. Of the 323 women (mean age = 32.2 ± 6.0 years) with 401 endometriomas included in our study, technical success was achieved in 377 endometriomas (94.0 %). No major complications were observed. In the multivariate analysis, a diameter < 3 cm (odds ratio, 25.641; p < 0.001), T2 dark signal intensity (odds ratio, 7.462; p = 0.001), and transvaginal access (odds ratio, 4.016; p = 0.004) were associated with technical failure.
Small endometrioma size (<3cm), T2 dark signal intensity, and transvaginal access were identified as significant risk factors for technical failure during catheter-directed sclerotherapy.
确定与导管引导下硬化治疗(CDS)技术结果相关的因素,并提出卵巢子宫内膜异位症患者CDS的选择标准。
这项回顾性研究纳入了2015年11月至2023年6月期间接受CDS治疗的子宫内膜异位症患者。使用术前磁共振成像评估子宫内膜异位症的特征,包括直径、形态(单房或多房)和T2信号强度。此外,还分析了导管尺寸(7或8.5法式)和穿刺途径(经腹与经阴道)。采用多因素逻辑回归分析来确定与CDS技术结果相关的因素。
技术成功定义为成功完成以下操作:1)将7或8.5法式导管插入子宫内膜异位症病灶;2)完全抽吸内部内容物;3)完成硬化治疗且无乙醇渗漏。在我们研究纳入的323名患有401个子宫内膜异位症的女性(平均年龄=32.2±6.0岁)中,377个子宫内膜异位症病灶(94.0%)实现了技术成功。未观察到重大并发症。在多因素分析中,直径<3cm(比值比,25.641;p<0.001)、T2低信号强度(比值比,7.462;p=0.001)和经阴道穿刺途径(比值比,4.016;p=0.004)与技术失败相关。
小尺寸子宫内膜异位症(<3cm)、T2低信号强度和经阴道穿刺途径被确定为导管引导下硬化治疗技术失败的重要危险因素。